$NOC

WELSH MARK A III sold $52K of NOC

WELSH MARK A III sold 95 shares of NORTHROP GRUMMAN CORP /DE/ (NOC) at an average of $547.53 ($544.53–$554.14) across 10 trades on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · WELSH MARK A III
Published Aug 4, 2026, 5:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 4, 2026, 6:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NOC
Neutral
high confidence
Mentioned
$NOC
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NOCNeutralLow
01

Why it matters

The disclosed fact is the sale size, trade date, and post-transaction holdings. It does not include any new guidance, contract award, regulatory action, or earnings datapoint.

02

Market read

Traders may treat this as routine insider activity with low signal value unless it is part of an unusual pattern.

03

What to watch

The article does not disclose whether the sale was part of a broader scheduled selling cadence, nor does it provide options activity or other related insider transactions.

Relevance 2/10Novelty 2/10Timing: filed 2026-08-04, transaction dated 2026-08-03

Background

The article is a SEC Form 4 insider transaction disclosure for Northrop Grumman, reported from an open-market sale by a director under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$NOCNeutralHigh confidence
Context

Northrop Grumman director Mark A. Welsh III sold $52,014.91 of NOC shares via an open-market sale under a pre-arranged 10b5-1 plan.

Expected impact

Limited near-term impact; any effect is likely sentiment-only and should fade unless follow-on filings show unusual selling.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 plan, and the article provides no new company-specific operational or financial information.

Market effects

Defense primes may see periodic insider 10b5-1 sales without signaling program or margin changes.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, clustered insider selling can sometimes coincide with private views on valuation or timing, so traders may watch for additional Form 4 sales.

Key entities

  • NORTHROP GRUMMAN CORP /DE/

    Subject of the Form 4 insider sale disclosure.

  • WELSH MARK A III

    Director who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RTXMed

Defense Watch: RTX C-UAS Award, MQ-25 Software Test, PrSM Inc. 4, Taiwan V-BAT, Autonomous Black Hawk

RTX's Raytheon received a $729M contract for C-UAS systems. Boeing tested MQ-25 software, enabling autonomous coordination. The Navy awarded MQ-25A production contracts and tested automatic landing gear retraction. AeroVironment's VideoRay demonstrated autonomous mine countermeasures. Lockheed Martin delivered a C-130J for TACAMO conversion, with Northrop Grumman integrating systems. ThinKom provided SATCOM antennas for the E-130J Phoenix II. XTEND, Orqa, and Swarm received DoD drone awards.

$LMTLow

U.S. Navy Receives C-130J-30 for Planned E-130J TACAMO Mission

The U.S. Navy received a C-130J-30 from Lockheed Martin for the E-130J TACAMO mission, which will replace the E-6B Mercury. The aircraft will be modified by Northrop Grumman under a $3.46B contract. The GAO noted potential development risks, including operational-availability concerns and manufacturing difficulties. The critical design review is scheduled for late 2027, with no operational service date provided.

$LMTMed

Redburn Starts Coverage of U.S. Defense Stocks With Buy Ratings on Lockheed, Northrop and Kratos

Redburn initiated coverage of U.S. defense stocks, rating Lockheed Martin (LMT), Northrop Grumman (NOC), and Kratos (KTOS) as 'buy' with price targets of $650, $680, and $70, respectively. AeroVironment (AVAV) was rated 'neutral'. The brokerage cited a proposed $1.5 trillion U.S. military budget for fiscal 2027 as a potential demand driver. Redburn forecasts significant revenue and earnings growth for these companies through 2030.